Stephanie Howe Guarino, MD
Hematology/Oncology- Bone Tumors
- Cancer Care
- Leukemia
- Lymphoma
- Solid Tumors
-
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel; Annals of Hematology; (2024).
-
AML in Distinct Age-Defined Populations of Infants, Adolescents and Young Adults; Pediatric Oncology; (2024).
-
COVID-19 in hospitalized adult patients with sickle cell disease: A 2020 US cohort using Cerner Real-World Data<sup>â„¢</sup>(CRWD); Journal of Clinical and Translational Science; (2023).
-
Peer Mediated Groups: Nonpharmacologic Management of Pain for and By Those with Sickle Cell Disease; Delaware Journal of Public Health; (2022).
-
How to utilize new therapies for sickle cell disease; Hematology (United States); (2022).
-
Reflections from physician scientists on the front lines of covid-19; Delaware Journal of Public Health; (2020).
- English